Pfenex
Pfenex is a biotechnology company that researches and develops biosimilar therapeutics for the treatment of osteoporosis and retinal diseases.
Business Model:
Revenue: $38.6M
Employees: 51-200
Rankings
Industries / Tags:
Detailed Pfenex Information
Pfenex was acquired by
Ligand Pharmaceuticals.
The acquisition happend on 2020-08-10.
Details of the transaction were not public
Acquirer
Geographic Data
Address: 10790 Roselle Street
City: San Diego
State: CA
Zip: 92121
Country: US
Financial Info
Stage:
post ipo equity
Raised Last:
$39M
Raised Total:$63M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Pfenex is a biotechnology company that researches and develops biosimilar therapeutics for the treatment of osteoporosis and retinal diseases.
Contact Phone:
+18583524400
Contact Email:
Pfenex went public on 7/18/2014 on the NYSE
Listed Exchange:
NYSE
IPO Date:
7/18/2014
Ticker Symbol:
PFNX
IPO Price:
$15.5/share
Amount Raised:
$41M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 7/2014 | IPO | $50M |
|
12/2009 | Series A | 2 | $24M |
Signet Healthcare Partners The Dow Chemical Company Signet Healthcare Partners Signet Healthcare Partners The Dow Chemical Company Signet Healthcare Partners |
5/2018 | Post-IPO Equity | $39.4M |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
